RTG 300 (Potiga 300 mg)

Generic Name: ezogabine

Pill imprint RTG 300 has been identified as Potiga 300 mg.

Potiga is used in the treatment of epilepsy; seizures and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 300 mg has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.

See also related documents.

Imprint Search

Images for RTG 300

Potiga 300 mg RTG 300
Potiga
Generic Name:
ezogabine
Imprint:
RTG 300
Strength:
300 mg
Color:
Green
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Neuronal potassium channel openers
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
5 - Some potential for abuse
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0813
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 2
hypromelloses
ferric oxide yellow
soya lecithin
magnesium stearate
microcrystalline cellulose
polyvinyl alcohol
magnesium silicate
titanium dioxide
xanthan gum

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)